A few examples of those newly discovered molecules that are now being evaluated in preclinical tumor models and/or even in clinical trials are lymphocyte activation gene 3 (LAG3) protein [91] and T cell immunoglobulin and mucin domain-containing 3 (TIM3) protein [92]. This evidence concerns the gene LAG3 and neoplasm.